Cargando…

3q26 Amplifications in Cervical Squamous Carcinomas

Background: Squamous carcinomas of the uterine cervix often carry mutations of the gene encoding for the catalytic sub-unit of kinase PI3K, PIK3CA. The locus of this gene at chromosome 3q26 and neighboring loci are also commonly amplified. The landscape of 3q26-amplified cases have not been previous...

Descripción completa

Detalles Bibliográficos
Autor principal:	Voutsadakis, Ioannis A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395483/ https://www.ncbi.nlm.nih.gov/pubmed/34436017 http://dx.doi.org/10.3390/curroncol28040251

Ejemplares similares

Cell Models for Chromosome 20q11.21 Amplification and Drug Sensitivities in Colorectal Cancer
por: Voutsadakis, Ioannis A.
Publicado: (2021)

SOX2 Is an Oncogene Activated by Recurrent 3q26.3 Amplifications in Human Lung Squamous Cell Carcinomas
por: Hussenet, Thomas, et al.
Publicado: (2010)

Characteristics and Prognosis of 8p11.23-Amplified Squamous Lung Carcinomas
por: Voutsadakis, Ioannis A.
Publicado: (2023)

8p11.23 Amplification in Breast Cancer: Molecular Characteristics, Prognosis and Targeted Therapy
por: Voutsadakis, Ioannis A.
Publicado: (2020)

Deletion polymorphism at chromosome 3q26.1 and oral squamous cell carcinoma
por: KAWACHI, HOMARE, et al.
Publicado: (2012)

Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma
por: Rao, Pulivarthi H, et al.
Publicado: (2004)

PI3KCA Mutations in Uterine Cervix Carcinoma
por: Voutsadakis, Ioannis A.
Publicado: (2021)

3q26 Amplification Is an Effective Negative Triage Test for LSIL: A Historical Prospective Study
por: Heitmann, Erica R., et al.
Publicado: (2012)

An Interstitial Deletion at 10q26.2q26.3
por: Iourov, Ivan Y., et al.
Publicado: (2014)

Amplification of 3q26.2, 5q14.3, 8q24.3, 8q22.3, and 14q32.33 Are Possible Common Genetic Alterations in Oral Cancer Patients
por: Ambele, Melvin A., et al.
Publicado: (2020)

Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas
por: Andersson, S, et al.
Publicado: (2006)

Gene‐level dissection of chromosome 3q locus amplification in squamous cell carcinoma of the lung using the nCounter assay
por: Jeon, Taesung, et al.
Publicado: (2023)

Identification of novel candidate target genes, including EPHB3, MASP1 and SST at 3q26.2–q29 in squamous cell carcinoma of the lung
por: Kang, Ji Un, et al.
Publicado: (2009)

Hormone Receptors in Serous Ovarian Carcinoma: Prognosis, Pathogenesis, and Treatment Considerations
por: Voutsadakis, Ioannis A.
Publicado: (2016)

EVI1, a target gene for amplification at 3q26, antagonizes transforming growth factor-β-mediated growth inhibition in hepatocellular carcinoma
por: Yasui, Kohichiroh, et al.
Publicado: (2015)

Pathogenesis of colorectal carcinoma and therapeutic implications: the roles of the ubiquitin–proteasome system and Cox-2
por: Voutsadakis, Ioannis A
Publicado: (2007)

Urothelial Bladder Carcinomas with High Tumor Mutation Burden Have a Better Prognosis and Targetable Molecular Defects beyond Immunotherapies
por: Voutsadakis, Ioannis A.
Publicado: (2022)

True 3q Chromosomal Amplification in Squamous Cell Lung Carcinoma by FISH and aCGH Molecular Analysis: Impact on Targeted Drugs
por: Brunelli, Matteo, et al.
Publicado: (2012)

Amplification and up-regulation of MIR30D was associated with disease progression of cervical squamous cell carcinomas
por: Zhou, You, et al.
Publicado: (2017)

Global gene expression profiling reveals a suppressed immune response pathway associated with 3q amplification in squamous carcinoma of the lung
por: Qian, Jun, et al.
Publicado: (2015)

The Genomic Environment of BRAF Mutated and BRAF/PIK3CA Double Mutated Colorectal Cancers
por: Voutsadakis, Ioannis A.
Publicado: (2022)

Characteristics and clinical outcomes of patients with acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2)
por: Richard-Carpentier, Guillaume, et al.
Publicado: (2023)

Sensitivities and Dependencies of BRAF Mutant Colorectal Cancer Cell Lines with or without PIK3CA Mutations for Discovery of Vulnerabilities with Therapeutic Potential
por: Voutsadakis, Ioannis A.
Publicado: (2022)

EGFR Mutation and 11q13 Amplification Are Potential Predictive Biomarkers for Immunotherapy in Head and Neck Squamous Cell Carcinoma
por: Dou, Shengjin, et al.
Publicado: (2022)

Oncogene Amplification in Squamous Cell Carcinoma of the Oral Cavity
por: Saranath, Dhananjaya, et al.
Publicado: (1989)

Neurotrophic receptor tyrosine kinase family members in secretory and non-secretory breast carcinomas
por: Stravodimou, Athina, et al.
Publicado: (2022)

Identification of SEC62 as a potential marker for 3q amplification and cellular migration in dysplastic cervical lesions
por: Linxweiler, Maximilian, et al.
Publicado: (2016)

Orbital Metastasis of Breast Carcinoma
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2009)

The Second Case of Non-Mosaic Trisomy of Chromosome 26 with Homologous Fusion 26q;26q in the Horse
por: Ghosh, Sharmila, et al.
Publicado: (2022)

Chromosome 8q as the most frequent target for amplification in early gastric carcinoma
por: KANG, JI UN
Publicado: (2014)

Mild Phenotype in a Patient with a De Novo 6.3 Mb Distal Deletion at 10q26.2q26.3
por: Tanteles, George A., et al.
Publicado: (2015)

Molecular Lesions of Insulator CTCF and Its Paralogue CTCFL (BORIS) in Cancer: An Analysis from Published Genomic Studies
por: Voutsadakis, Ioannis A.
Publicado: (2018)

High Mutation Burden in ER-Positive/HER2-Negative/Luminal Breast Cancers
por: Voutsadakis, Ioannis A.
Publicado: (2022)

Molecular Alterations and Putative Therapeutic Targeting of Planar Cell Polarity Proteins in Breast Cancer
por: Voutsadakis, Ioannis A.
Publicado: (2023)

Comparison of Clinical Subtypes of Breast Cancer within the Claudin-Low Molecular Cluster Reveals Distinct Phenotypes
por: Voutsadakis, Ioannis A.
Publicado: (2023)

EMT Features in Claudin-Low versus Claudin-Non-Suppressed Breast Cancers and the Role of Epigenetic Modifications
por: Voutsadakis, Ioannis A.
Publicado: (2023)

Tight Junction Claudins and Occludin Are Differentially Regulated and Expressed in Genomically Defined Subsets of Colon Cancer
por: Voutsadakis, Ioannis A.
Publicado: (2023)

The prognostic value of EGFR overexpression and amplification in Esophageal squamous cell Carcinoma
por: Jiang, Dongxian, et al.
Publicado: (2015)

Amplification at 9p in Cervical Carcinoma by Comparative Genomic Hybridization
por: Jee, Kowan J., et al.
Publicado: (2001)

Mutations of p53 associated with pancreatic cancer and therapeutic implications
por: Voutsadakis, Ioannis A.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ht6nbebfv9pk3sq15i9e6sgt0t